Critics say exemption exploits White House’s ‘self-made gas crisis’, and could doom the rare Rice’s whale Sign up for the Breaking News US email to get newsletter alerts in your inbox A US government panel on Tuesday exempted oil and gas drilling in the Gulf of Mexico from the Endangered Species Act (ESA), a move which critics say could doom a rare whale species and harm other marine life . The En...
Critics say exemption exploits White House’s ‘self-made gas crisis’, and could doom the rare Rice’s whale Sign up for the Breaking News US email to get newsletter alerts in your inbox A US government panel on Tuesday exempted oil and gas drilling in the Gulf of Mexico from the Endangered Species Act (ESA), a move which critics say could doom a rare whale species and harm other marine life . The Endangered Species Committee – which had not convened in more than three decades – voted to approve the request for the ESA exemption at the request of the defense secretary, Pete Hegseth . Continue reading...
Alexey_Fedoren Piper Sandler has initiated Regeneron Pharmaceuticals ( REGN ) at overweight saying that it expects continued growth in Dupixent (dupilumab) sales as well as "several high-potential pipeline assets." The firm set a price target of $875 (~17% upside based on March 30 close). Analyst Biren Amin is projecting Dupixent sales to surge ~50% from 2025-2030, reaching about ~$20B by the end ...
Alexey_Fedoren Piper Sandler has initiated Regeneron Pharmaceuticals ( REGN ) at overweight saying that it expects continued growth in Dupixent (dupilumab) sales as well as "several high-potential pipeline assets." The firm set a price target of $875 (~17% upside based on March 30 close). Analyst Biren Amin is projecting Dupixent sales to surge ~50% from 2025-2030, reaching about ~$20B by the end of that period. He noted that the company has done well to ameliorate competition from standard-dose Eylea (aflibercept) with Eylea HD, as the latter now accounts for 47% of the franchise's sales in the US. Amin added that loss of sales to biosimilars should be lessened by an anticipated Q2 approval of a prefilled syringe ("could serve as the next catalyst for REGN shares") and the recent approval of monthly dosing. Amin called Regeneron's pipeline "underappreciated," emphasizing its Factor XI antibody program. He models peak risk-adjusted sales of (REGN7508/REGN9933) of $2.7B compared to the consensus of $1.1B. "By decoupling efficacy from bleeding risk, this next-generation anticoagulation approach has the potential to unlock the ~50% of the market currently untreated due to safety concerns." Elsewhere in the pipeline, other potential long-term revenue drivers are "fianlimab in metastatic melanoma, cemidisiran in immunology, and cat/birch allergy programs." More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) Presents at Leerink Global Healthcare Conference 2026 Transcript Regeneron: Fairly Valued Now After A Stellar Upswing Regeneron Pharmaceuticals, Inc. (REGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Regeneron-licensed obesity drug shows positive phase 3 results in China FDA issues draft guidance to relax testing rules to encourage biosimilar drugs
frantic00 After three days in the red, weighed down by the volatility in the energy markets and the fluid geopolitical climate, shares of Norwegian Cruise Line Holdings ( NCLH ) are grinding higher, buoyed by a retreat in oil prices and an endorsement from Stifel. In a note to clients after the company’s investor event, Stifel analyst Steven Wieczynski believes investors are incorrectly assuming m...
frantic00 After three days in the red, weighed down by the volatility in the energy markets and the fluid geopolitical climate, shares of Norwegian Cruise Line Holdings ( NCLH ) are grinding higher, buoyed by a retreat in oil prices and an endorsement from Stifel. In a note to clients after the company’s investor event, Stifel analyst Steven Wieczynski believes investors are incorrectly assuming management is “talking down yield guidance for the remainder of 2026." “In our view, NOTHING (and we can’t say this loud enough) has changed versus when we met with [CEO John Chidsey] in mid-March,” Wieczynski says, noting that the company withheld yield guidance for the second half of this year to emphasize that Q3 will be the toughest from a yield perspective, with most of their inventory in weaker European and Alaskan markets. “It absolutely makes sense for NCLH to be conservative [with FY26 guidance]. With a new CEO plus an activist on the scene, why not just write off 2026 and give the company time to focus on 2027, as nothing really can be done at this point in 2026 given the elongated booking window of the cruise industry?” Wieczynski says. At issue is the company’s 2026 guidance and comments surrounding pressure on pricing and yields. During the earnings call with analysts , CFO Mark Kempa noted that Norwegian entered 2026 slightly behind an ideal booking curve in certain itineraries, “creating near-term pressure on pricing and yield, which is evidenced in guidance.” Accordingly, Norwegian now expects its net yield to contract ~1.6% as higher occupancy is offset by pricing pressures. For the balance of the year, net yields are expected to stabilize and “modestly improve” by 0.6%, bringing full-year net yields to approximately flat. As this conservatism likely spooked investors, Wieczynski believes this fueled a “significant dislocation” in the share price/valuation and that investors are overlooking two important factors in regard to NCLH. First, the company has adeq...
Nvidia (NASDAQ:NVDA) is back in a bear market, and with the $170 support level breaking down, the next stop might lie closer to $140 per share. Undoubtedly, that’d represent another 15% dip from current levels. And while shares have gone from cheap to cheaper in recent weeks, with shares now going for 33.6 times trailing ... Why I’m Staying Cautious on NVIDIA—and the Stocks I Prefer Instead
Nvidia (NASDAQ:NVDA) is back in a bear market, and with the $170 support level breaking down, the next stop might lie closer to $140 per share. Undoubtedly, that’d represent another 15% dip from current levels. And while shares have gone from cheap to cheaper in recent weeks, with shares now going for 33.6 times trailing ... Why I’m Staying Cautious on NVIDIA—and the Stocks I Prefer Instead
Konoplytska Rising oil prices ( CO1:COM ), ( CL1:COM ) could indirectly affect consumer delinquencies, as slower economic growth may pressure unemployment upwards, thereby increasing the share of borrowers unable to service their debt, according to Goldman Sachs analysts. While the direct impact of fuel costs ( XB1:COM ) on loan defaults remains limited, Ben Shumway, Goldman Sachs analyst, warned ...
Konoplytska Rising oil prices ( CO1:COM ), ( CL1:COM ) could indirectly affect consumer delinquencies, as slower economic growth may pressure unemployment upwards, thereby increasing the share of borrowers unable to service their debt, according to Goldman Sachs analysts. While the direct impact of fuel costs ( XB1:COM ) on loan defaults remains limited, Ben Shumway, Goldman Sachs analyst, warned that risks are skewed to the downside should the Middle East conflict persist long enough to dampen growth in the second half of the year. WTI crude oil ( CL1:COM ) prices have surged nearly 50% since the initial strikes in Iran, cascading into a nationwide increase of nearly $1 per gallon of gasoline. Consumer sentiment has dropped 3.3 points month over month, bringing the University of Michigan index under its 2nd percentile value since the late 1970s. This reading is notably lower than levels seen during both the early 2000s tech bubble and the bottom of the Global Financial Crisis. University of Michigan Consumer Sentiment Survey Index (University of Michigan, Goldman Sachs Global Investment Research) Nonetheless, the “direct transmission mechanism for oil price increases to impact consumer delinquencies remains weak,” the analyst explained. Gasoline accounts for only 3.4% of the average U.S. household’s total expenditures, meaning even a 50% price increase sustained for six months would raise overall household spending by approximately 84 basis points—likely insufficient to trigger any meaningful rise in defaults. Moreover, examining sector-specific trends, Shumway found little correlation between oil prices ( CL1:COM ), ( CO1:COM ) and delinquency rates across subprime auto, unsecured consumer loans, and credit cards. “Credit card delinquency changes appear to have no discernible trend or connection to oil prices,” he said, noting that past apparent correlations in subprime auto lending during the run-up to the Global Financial Crisis were likely driven by other macro...
Active fixed-income ETFs are entering a new phase of growth, driven by investor demand, structural advantages and expanding product breadth. In this episode of Inside Active, host David Cohne, mutual fund and active management analyst at Bloomberg Intelligence, speaks with Jeff Johnson, head of Fixed Income Product at Vanguard, about the rapid rise of active bond ETFs and why fixed income remains ...
Active fixed-income ETFs are entering a new phase of growth, driven by investor demand, structural advantages and expanding product breadth. In this episode of Inside Active, host David Cohne, mutual fund and active management analyst at Bloomberg Intelligence, speaks with Jeff Johnson, head of Fixed Income Product at Vanguard, about the rapid rise of active bond ETFs and why fixed income remains a compelling space for active management. They discuss Vanguard’s expansion beyond its indexing root
European Inflation Jumps Most Since 2022 On Soaring Energy Prices Even As Core CPI Unexpectedly Shrinks In an early preview of the coming inflation spike, the euro area saw its steepest jump in inflation since 2022 as the Iran war pushed energy costs sharply higher, backing expectations that the ECB will have to raise interest rates. In March, European consumer prices rose 2.5% from a year ago in ...
European Inflation Jumps Most Since 2022 On Soaring Energy Prices Even As Core CPI Unexpectedly Shrinks In an early preview of the coming inflation spike, the euro area saw its steepest jump in inflation since 2022 as the Iran war pushed energy costs sharply higher, backing expectations that the ECB will have to raise interest rates. In March, European consumer prices rose 2.5% from a year ago in March - and up a whopping 1.9% from the previous month - to the highest since January 2025. The silver lining: the median estimate was for an even higher 2.6% print. Yet while headline inflation soared, demand destruction appears to have depressed other purchases, and core inflation, which excludes volatile items like food and energy, unexpectedly slowed to 2.3%, while the closely watched services gauge also eased, Eurostat said Tuesday. Some more details from Goldman: Euro area headline HICP inflation increased by 0.63pp to 2.52%yoy in March, below our tracking and consensus of 2.6%yoy. Core HICP inflation, excluding energy, food, alcohol and tobacco, went down 15bp to 2.26%yoy, broadly in line with our latest tracking estimate but below consensus expectations of 2.4%yoy. The breakdown by main expenditure categories showed services inflation declining to 3.23%yoy, with part of the decline likely driven by Olympics-induced tourism and hospitality-related components payback in Italy, while non-energy industrial goods inflation went down to 0.47%yoy, surprising our latest tracking estimate to the downside. Of the non-core components, energy inflation increased to 4.9%yoy, close to our latest tracking but lower than we initially expected, while food, alcohol and tobacco inflation decline to 2.35%yoy, weaker than we expected. Using our seasonal adjustment methodology, aimed to closely replicate the ECB's, and removing the Easter adjustment for the whole services basket, we estimate that seasonally adjusted sequential core inflation was 0.08%mom in March, down from 0.33%mom in t...